News Focus
News Focus
icon url

iwasadiver

02/11/21 8:36 PM

#354408 RE: Bob_LobLaw #354247

It’s the same vaccine and UCLA has the rights to use it within trials not sponsored by NWBO. They can’t use the trademarked name and they have no ability to produce it outside clinical trials or to sell it. None. All patents and rights are owned by NWBO
icon url

sentiment_stocks

02/11/21 10:23 PM

#354433 RE: Bob_LobLaw #354247

They are the same thing. I knew this, and Linda Liau told me this herself.
icon url

Dr Bala

02/11/21 10:30 PM

#354435 RE: Bob_LobLaw #354247

The UCLA Combo Project I Trial uses DCVax-L. Here is the UCLA link (courtesy of moderation23) that says that UCLA uses DCVax-L:
https://cancer.ucla.edu/research/ucla-brain-spore/research-projects

Finally, in Aim 3, we will develop and validate predictive tumor, immunological and imaging biomarkers of response in recurrent glioblastoma patients enrolled in a Phase II clinical trial of DCVax-L +/- PD-1 blockade.